Veit L Bücklein (V Bücklein, Veit Buecklein, Veit Bücklein)

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 28

Top Topics

Acute Myeloid Leukemia

Locally Advanced

Top Venues

Science advances

This page only lists publications with an associated author ORCID identifier.

Publications

Kai Rejeski, Yucai Wang, Doris K Hansen, Gloria Iacoboni, Emmanuel Bachy, Radhika Bansal, Olaf Penack, Fabian Müller, Wolfgang Andreas Bethge, Javier Munoz, Razan Mohty, Veit L Bücklein, Pere Barba, Frederick L Locke, Yi Lin, Michael D Jain, Marion Subklewe
Applying the EHA/EBMT Grading for ICAHT after CAR-T: Comparative Incidence and Association with Infections and Mortality. Blood advances (2024)
Gerulf Hänel, Anne Schönle, Anne-Sophie Neumann, Daniel Nixdorf, Nora Philipp, Monika Sponheimer, Alexandra Leutbecher, Alica-Joana Emhardt, Giulia Magno, Veit L Bücklein, Jan Eckmann, Diana Dunshee, Vesna Kramar, Koorosh Korfi, Sara Colombetti, Pablo Umaña, Christiane Neumann, Marion Subklewe
Combining venetoclax and azacytidine with T-cell bispecific antibodies for treatment of acute myeloid leukemia: a preclinical assessment. Leukemia 38 (2) (2024)
Gerulf Hänel, Anne Schönle, Anne-Sophie Neumann, Daniel Nixdorf, Nora Philipp, Monika Sponheimer, Alexandra Leutbecher, Alica-Joana Emhardt, Giulia Magno, Veit L Bücklein, Jan Eckmann, Diana Dunshee, Vesna Kramar, Koorosh Korfi, Sara Colombetti, Pablo Umaña, Christiane Neumann, Marion Subklewe
Combining venetoclax and azacytidine with T-cell bispecific antibodies for treatment of acute myeloid leukemia: a preclinical assessment. Leukemia 38 (2) (2024)
Maryam Kazerani, Anetta Marcinek, Nora Philipp, Bettina Brauchle, Jonathan Jonas Taylor, Helena Domínguez Moreno, Andrea Terrasi, Benjamin Tast, Lisa Rohrbacher, Yingshuai Wang, Maximilian Warm, Alica-Joana Emhardt, Giulia Magno, Karsten Spiekermann, Tobias Herold, Tobias Straub, Sebastian Theurich, Gunnar Schotta, Roman Kischel, Veit L Bücklein, Marion Subklewe
Evolution of T-cell fitness through AML progression: enhanced bispecific T-cell engager-mediated function of bone marrow T cells at remission compared to initial diagnosis and relapse. Leukemia (2024)
Marion Subklewe, Yucai Wang, Doris K Hansen, Gloria Iacoboni, Emmanuel Bachy, Radhika Bansal, Olaf Penack, Fabian Müller, Wolfgang Andreas Bethge, Javier Munoz, Razan Mohty, Veit L Bücklein, Pere Barba, Frederick L Locke, Yi Lin, Michael D Jain, Marion Subklewe
Applying the EHA/EBMT grading for ICAHT after CAR-T: comparative incidence and association with infections and mortality. Blood advances 8 (8) (2024)
Gerulf Hänel, Anne Schönle, Anne-Sophie Neumann, Daniel Nixdorf, Nora Philipp, Monika Sponheimer, Alexandra Leutbecher, Alica-Joana Emhardt, Giulia Magno, Veit L Bücklein, Jan Eckmann, Diana Dunshee, Vesna Kramar, Koorosh Korfi, Sara Colombetti, Pablo Umaña, Christiane Neumann, Marion Subklewe
Combining venetoclax and azacytidine with T-cell bispecific antibodies for treatment of acute myeloid leukemia: a preclinical assessment. Leukemia 38 (2) (2024)
Gerulf Hänel, Anne Schönle, Anne-Sophie Neumann, Daniel Nixdorf, Nora Philipp, Monika Sponheimer, Alexandra Leutbecher, Alica-Joana Emhardt, Giulia Magno, Veit L Bücklein, Jan Eckmann, Diana Dunshee, Vesna Kramar, Koorosh Korfi, Sara Colombetti, Pablo Umaña, Christiane Neumann, Marion Subklewe
Combining venetoclax and azacytidine with T-cell bispecific antibodies for treatment of acute myeloid leukemia: a preclinical assessment. Leukemia 38 (2) (2024)
Gerulf Hänel, Anne Schönle, Anne-Sophie Neumann, Daniel Nixdorf, Nora Philipp, Monika Sponheimer, Alexandra Leutbecher, Alica-Joana Emhardt, Giulia Magno, Veit L Bücklein, Jan Eckmann, Diana Dunshee, Vesna Kramar, Koorosh Korfi, Sara Colombetti, Pablo Umaña, Christiane Neumann, Marion Subklewe
Combining venetoclax and azacytidine with T-cell bispecific antibodies for treatment of acute myeloid leukemia: a preclinical assessment. Leukemia (2024)
Gerulf Hänel, Anne Schönle, Anne-Sophie Neumann, Daniel Nixdorf, Nora Philipp, Monika Sponheimer, Alexandra Leutbecher, Alica-Joana Emhardt, Giulia Magno, Veit L Bücklein, Jan Eckmann, Diana Dunshee, Vesna Kramar, Koorosh Korfi, Sara Colombetti, Pablo Umaña, Christiane Neumann, Marion Subklewe
Combining venetoclax and azacytidine with T-cell bispecific antibodies for treatment of acute myeloid leukemia: a preclinical assessment. Leukemia 38 (2) (2024)
Marion Subklewe, Yucai Wang, Doris K Hansen, Gloria Iacoboni, Emmanuel Bachy, Radhika Bansal, Olaf Penack, Fabian Müller, Wolfgang Andreas Bethge, Javier Munoz, Razan Mohty, Veit L Bücklein, Pere Barba, Frederick L Locke, Yi Lin, Michael D Jain, Marion Subklewe
Applying the EHA/EBMT grading for ICAHT after CAR-T: comparative incidence and association with infections and mortality. Blood advances 8 (8) (2024)
Gerulf Hänel, Anne Schönle, Anne-Sophie Neumann, Daniel Nixdorf, Nora Philipp, Monika Sponheimer, Alexandra Leutbecher, Alica-Joana Emhardt, Giulia Magno, Veit L Bücklein, Jan Eckmann, Diana Dunshee, Vesna Kramar, Koorosh Korfi, Sara Colombetti, Pablo Umaña, Christiane Neumann, Marion Subklewe
Combining venetoclax and azacytidine with T-cell bispecific antibodies for treatment of acute myeloid leukemia: a preclinical assessment. Leukemia 38 (2) (2024)
Marion Subklewe, Yucai Wang, Doris K Hansen, Gloria Iacoboni, Emmanuel Bachy, Radhika Bansal, Olaf Penack, Fabian Müller, Wolfgang Andreas Bethge, Javier Munoz, Razan Mohty, Veit L Bücklein, Pere Barba, Frederick L Locke, Yi Lin, Michael D Jain, Marion Subklewe
Applying the EHA/EBMT grading for ICAHT after CAR-T: comparative incidence and association with infections and mortality. Blood advances 8 (8) (2024)
Marion Subklewe, Yucai Wang, Doris K Hansen, Gloria Iacoboni, Emmanuel Bachy, Radhika Bansal, Olaf Penack, Fabian Müller, Wolfgang Andreas Bethge, Javier Munoz, Razan Mohty, Veit L Bücklein, Pere Barba, Frederick L Locke, Yi Lin, Michael D Jain, Marion Subklewe
Applying the EHA/EBMT grading for ICAHT after CAR-T: comparative incidence and association with infections and mortality. Blood advances 8 (8) (2024)
Daniel Nixdorf, M Sponheimer, D Berghammer, Fabian Engert, U Bader, Nora Philipp, Maryam Kazerani, T Straub, L Rohrbacher, Lucas Esteban Wange, S Dapa, D Atar, C M Seitz, K Brandstetter, A Linder, M von Bergwelt, Heinrich Leonhardt, J Mittelstaet, A Kaiser, Veit L Bücklein, Marion Subklewe
Adapter CAR T cells to counteract T-cell exhaustion and enable flexible targeting in AML. Leukemia (2023)
Marion Subklewe, David M Cordas Dos Santos, Nathan H Parker, Veit L Bücklein, Michael Winkelmann, Khushali S Jhaveri, Lian Liu, Paul Trinkner, Sophie Günther, Philipp Karschnia, Viktoria Blumenberg, Christian Schmidt, Wolfgang Gerhard Kunz, Michael von Bergwelt-Baildon, Michael D Jain, Sebastian Theurich, Marion Subklewe
Influence of adipose tissue distribution, sarcopenia, and nutritional status on clinical outcomes after CD19 CAR T-cell therapy. Cancer immunology research (2023)
Marion Subklewe, Ariel Perez, Gloria Iacoboni, Viktoria Blumenberg, Veit L Bücklein, Simon Völkl, Olaf Penack, Omar Albanyan, Sophia Stock, Fabian Müller, Philipp Karschnia, Agnese Petrera, Kayla M Reid, Rawan G Faramand, Marco L Davila, Karnav Modi, Erin A Dean, Christina A Bachmeier, Michael von Bergwelt-Baildon, Frederick L Locke, Wolfgang Andreas Bethge, Lars Bullinger, Andreas Mackensen, Pere Barba, Michael D Jain, Marion Subklewe
Severe hematotoxicity after CD19 CAR-T therapy is associated with suppressive immune dysregulation and limited CAR-T expansion. Science advances 9 (38) (2023)
Viktoria Blumenberg, Busch Galina, Stephan Baumann, Regina Jitschin, Gloria Iacoboni, Eva Hoster, Laura Gallur, Josu Iraola-Truchuelo, Michael Winkelmann, Konstantin Hellwig, Christian Schmidt, Lisa Frölich, Benjamin Tast, Friederike Hildebrand, Kai Rejeski, Franziska J Dekorsy, Christian Schmidkonz, Tobias Bäuerle, Wolfgang Gerhard Kunz, Dimitrios Mougiakakos, Fabian Müller, Michael von Bergwelt-Baildon, Pere Barba, Veit L Bücklein, Andreas Mackensen, Simon Völkl, Marion Subklewe
Early quantification of anti-CD19 CAR T-cells by flow cytometry predicts response in R/R DLBCL. Blood advances (2023)
Peter Bader, Claudia Rossig, Martin Hutter, Francis Ayuketang Ayuk, Claudia D Baldus, Veit L Bücklein, Halvard Bonig, Gunnar Cario, Hermann Einsele, Udo Holtick, Christian Koenecke, Shahrzad Bakhtiar, Annette Künkele, Richard P Meisel, Fabian Mueller, Ingo Müller, Olaf Penack, Eva Rettinger, Martin G Sauer, Paul-Gerhardt Schlegel, Jan Soerensen, Arend von Stackelberg, Brigitte Strahm, Tobias Feuchtinger, Julia Hauer, Andrea Jarisch
CD19-CAR-T cells are an effective therapy of post-transplant relapse in B- ALL patients: Real-World Data from Germany. Blood advances (2023)
Nora Philipp, Maryam Kazerani, Alyssa Nicholls, Binje Vick, Jan Wulf, Tobias Straub, Michaela Scheurer, Amelie Muth, Gerulf Hänel, Daniel Nixdorf, Monika Sponheimer, Malte Ohlmeyer, Sonja M Lacher, Bettina Brauchle, Anetta Marcinek, Lisa Rohrbacher, Alexandra Leutbecher, Kai Rejeski, Oliver Weigert, Michael von Bergwelt-Baildon, Sebastian Theurich, Roman Kischel, Irmela Jeremias, Veit L Bücklein, Marion Subklewe
T-cell exhaustion induced by continuous bispecific molecule exposure is ameliorated by treatment-free intervals. Blood 140 (10) (2022)
Wolfgang Andreas Bethge, Peter Martus, Michael Schmitt, Udo Holtick, Marion Subklewe, Bastian von Tresckow, Francis Ayuk, Eva Maria Wagner-Drouet, Gerald G Wulf, Reinhard Marks, Olaf Penack, Ulf Schnetzke, Christian Koenecke, Malte von Bonin, Matthias Stelljes, Bertram Glass, Claudia D Baldus, Vladan Vucinic, Dimitrios Mougiakakos, Max Topp, Matthias A Fante, Roland Schroers, Lale Bayir, Peter Borchmann, Veit L Bücklein, Justin Hasenkamp, Christine Hanoun, Simone Thomas, Dietrich W Beelen, Claudia Lengerke, Nicolaus Kroeger, Peter Dreger
GLA/DRST real-world outcome analysis of CAR T-cell therapies for large B-cell lymphoma in Germany. Blood 140 (4) (2022)
Marion Subklewe, Zhijie Wu, Viktoria Blumenberg, Wolfgang Gerhard Kunz, Susanna Müller, Sachiko Kajigaya, Shouguo Gao, Veit L Bücklein, Lisa Frölich, Christian Schmidt, Michael von Bergwelt-Baildon, Xingmin Feng, Neal S Young, Marion Subklewe
Oligoclonal T-cell expansion in a patient with bone marrow failure after CD19 CAR-T therapy for Richter-transformed DLBCL. Blood 140 (20) (2022)
Maximilian A Röhnert, Michael Kramer, Jonas Schadt, Philipp Ensel, Christian Thiede, Stefan W Krause, Veit L Bücklein, Jörg Hoffmann, Sonia Jaramillo, Richard F Schlenk, Christoph Röllig, Martin Bornhäuser, Nicholas McCarthy, Sylvie D Freeman, Uta Oelschlägel, Malte Bonin
Reproducible measurable residual disease detection by multiparametric flow cytometry in acute myeloid leukemia. Leukemia 36 (9) (2022)
Marion Subklewe, Andreas Burchert, Gloria Iacoboni, Pierre Sesques, Lars Fransecky, Veit L Bücklein, Corinna Trenker, Rafael Hernani, Ralph Naumann, Jonas A Schäfer, Viktoria Blumenberg, Christian Schmidt, Kristina Sohlbach, Michael von Bergwelt-Baildon, Emmanuel Bachy, Pere Barba
Safety and feasibility of stem cell boost as a salvage therapy for severe hematotoxicity after CD19 CAR T-cell therapy. Blood advances 6 (16) (2022)
Florian Schoeberl, Steffen Tiedt, Anita Schmitt, Viktoria Blumenberg, Philipp Karschnia, Vanessa Granja Burbano, Veit L Bücklein, Marion Subklewe, Christian Schmidt, Galina Busch, Michael von Bergwelt-Baildon, Jörg-Christian Tonn, Michael Schmitt, Marion Subklewe, Louisa von Baumgarten
Neurofilament light chain serum levels correlate with the severity of neurotoxicity after CAR T-cell treatment. Blood advances 6 (10) (2022)
Michael Heuser, Sylvie D Freeman, Gert J Ossenkoppele, Francesco Buccisano, Christopher S Hourigan, Lok Lam Ngai, Jesse Marc Tettero, Costa Bachas, Constance Baer, Marie Christine Bene, Veit L Bücklein, Anna Czyz, Barbara Denys, Richard Dilon, Michaela Feuring-Buske, Monica L Guzman, Torsten Haferlach, Lina Han, Julia K Herzig, Jeffrey L Jorgensen, Wolfgang Kern, Marina Y Konopleva, Francis Lacombe, Marta Libura, Agata Majchrzak, Luca Maurillo, Yishai Ofran, Jan Philippé, Adriana Plesa, Claude Preudhomme, Farhad Ravandi, Christophe Roumier, Marion Subklewe, Felicitas Thol, Arjan A van de Loosdrecht, Bert A van der Reijden, Adriano Venditti, Agnieszka Świątek, Peter J M Valk, Brent L Wood, Roland Bruno Walter, Christian Thiede, Konstanze Döhner, Gail J Roboz, Jacqueline Cloos
2021 Update Measurable Residual Disease in Acute Myeloid Leukemia: European LeukemiaNet Working Party Consensus Document. Blood (2021)
Kai Rejeski, Ariel Perez Perez, Pierre Sesques, Eva Hoster, Carolina Susanna Berger, Liv Jentzsch, Dimitrios Mougiakakos, Lisa Frölich, Josephine Ackermann, Veit L Bücklein, Viktoria Blumenberg, Christian Schmidt, Laurent Jallades, Boris Fehse, Christoph Faul, Philipp Karschnia, Oliver Weigert, Martin Dreyling, Frederick L Locke, Michael von Bergwelt-Baildon, Andreas Mackensen, Wolfgang Andreas Bethge, Francis Ayuk, Emmanuel Bachy, Gilles Andre Salles, Michael D Jain, Marion Subklewe
CAR-HEMATOTOX: A model for CAR T-cell related hematological toxicity in relapsed/refractory large B-cell lymphoma. Blood (2021)
Bettina Brauchle, Rebecca L Goldstein, Christine M Karbowski, Anja Henn, Chi-Ming Li, Veit L Bücklein, Christina Krupka, Michael C Boyle, Priya Koppikar, Sascha Haubner, Joachim Wahl, Christoph Dahlhoff, Tobias Raum, Matthew J Rardin, Christine Sastri, Dan A Rock, Michael von Bergwelt-Baildon, Brendon Frank, Klaus H Metzeler, Ryan Case, Matthias Friedrich, Mercedesz Balazs, Karsten Spiekermann, Angela Coxon, Marion Subklewe, Tara Arvedson
Characterization of a Novel FLT3 BiTE Molecule for the Treatment of Acute Myeloid Leukemia. Molecular cancer therapeutics 19 (9) (2020)
Veit L Bücklein, Christina Limmroth, Eric Kampmann, Gesa Schuebbe, Rolf Issels, Falk Roeder, Martin Angele, Hans-Roland Dürr, Thomas Knösel, Sultan Abdel-Rahman, Dorit Di Gioia, Lars Hartwin Lindner
Ifosfamide, Carboplatin, and Etoposide (ICE) in Combination with Regional Hyperthermia as Salvage Therapy in Patients with Locally Advanced Nonmetastatic and Metastatic Soft-Tissue Sarcoma. Sarcoma 2020 (2020)